Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Dem Senate primary erupts in key state as...
Trump-backed candidate aims to pad GOP’s fragile House...
White House unleashes on Stacey Abrams in latest...
Ilhan Omar calls Trump an ‘unhinged lunatic,’ urges...
Former Virginia Gov Glenn Youngkin hints at political...
Trump’s apocalyptic Iran warning raises stakes for sweeping...
Graham eyes ‘down payment’ on Trump-backed SAVE Act...
Midterm alarm bells: Democrats face steep favorability deficit...
Democrat whose parents fled Iran moves to oust...
American journalist kidnapped in Iraq is set free,...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

Teenage cancer patient’s final fight becomes law as House passes landmark pediatric bill

by admin December 6, 2025
December 6, 2025
Teenage cancer patient’s final fight becomes law as House passes landmark pediatric bill

A teenage girl who spent her final years advocating for young people battling cancer is forever memorialized in history, thanks to a key bill passed by the House of Representatives.

Mikaela Naylon was just 16 when she died five years after being diagnosed with osteosarcoma, a rare form of bone cancer.

Rep. Michael McCaul, R-Texas, who helped lead the landmark legislation that became her namesake, said Mikaela spent much of that time fighting to give fellow children a chance to survive cancer.

He told Fox News Digital that he viewed childhood cancer patients as ‘the best advocates’ for their cause, calling them his ‘better angels.’

‘Mikaela was a great example of that,’ McCaul said. ‘She was very sick. She’d just undergone radiation and chemotherapy. She wasn’t feeling very well, and I could tell. But she still made the effort to come to Washington, to go to members’ offices and advocate for the legislation.’

The Mikaela Naylon Give Kids A Chance Act is aimed at expanding children’s access to existing cancer therapy trials, as well as incentivizing development of treatments and solutions for pediatric cancer.

It reauthorizes funding for the National Institutes of Health (NIH) to support pediatric disease research through fiscal year 2027, and extends the Food and Drug Administration’s (FDA) ability to expedite review of drugs aimed at helping certain pediatric illnesses.

‘It’s probably one of the most rewarding things I’ve done is to not only draw awareness to childhood cancer by forming the [Childhood Cancer Caucus] and then having an annual summit, but to be able to pass legislation that results in saving children’s lives. I don’t think there’s anything more important than that,’ McCaul said.

His bill passed the House unanimously on Monday, with both Republicans and Democrats speaking out in strong support for the legislation.

Mikaela’s family was in attendance to watch both its passage and the speeches lawmakers gave in favor of it.

‘Nothing will take the place of her. But it helped fill kind of a void, an emptiness they have right now. And they’re very proud of that, that her legacy is carried on through this legislation,’ McCaul, who also gave the Naylon family a tour of the U.S. Capitol, said.

Mikaela’s parents Kassandra and Doug, and her brother Ayden, told Fox News Digital that she had ‘faced every day with hope, purpose and a fierce determination to make the world better for the kids who would come after her.’

‘She believed that all children, no matter how rare their diagnosis, deserve access to the most promising treatments and a real chance at life. This legislation reflects that mission,’ the Naylon family told Fox News Digital.

They thanked McCaul as well as Reps. Debbie Dingell, D-Mich., and Gus Bilirakis, R-Fla., for championing the bill, as well as advocacy groups who also helped shepherd it forward.

‘Their commitment ensures that Mikaela‘s voice, and the voices of so many brave children like her, will forever be heard in the halls of Congress,’ the family said.

This post appeared first on FOX NEWS

previous post
State-level AI rules survive — for now — as Senate sinks moratorium despite White House pressure
next post
Trump signs off on nationwide vaccine schedule review as CDC withdraws infant hep B guidance: ‘Fast track’

You may also like

Somber Walz spotted on daughter’s Instagram after election...

November 9, 2024

Bessent mocks Newsom at Davos as ‘Patrick Bateman...

January 21, 2026

Trump campaign says internal communications were hacked, including...

August 11, 2024

Russia to ‘interrogate’ two suspects in attempted assassination...

February 7, 2026

Macron vows nuclear arsenal boost as Europe turns...

March 5, 2026

Trump says Ric Grenell will be ‘high up’...

December 12, 2024

Gingrich & Walker: Kamala Harris’ abandoned astronauts should...

August 31, 2024

New RNC chair Joe Gruters vows to ‘ride...

August 24, 2025

Five biggest moments of Trump’s speech to RNC

July 19, 2024

The history of how Trump and Bolton’s relationship...

August 23, 2025

Recent Posts

  • Dem Senate primary erupts in key state as candidate teams up with radical streamer: ‘America deserved 9/11’
  • Trump-backed candidate aims to pad GOP’s fragile House majority battle in showdown for MTG’s seat
  • White House unleashes on Stacey Abrams in latest clash over Trump’s election order
  • Ilhan Omar calls Trump an ‘unhinged lunatic,’ urges booting him out of office
  • Former Virginia Gov Glenn Youngkin hints at political future, says he’s ‘chomping at the bit’ after exit

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,017)
    • Investing (4,320)
    • Politics (5,303)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 Sightful Invest. All Rights Reserved.